(Q37857043)

24 August 2017

title

Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures (English)

1 reference

24 August 2017

0 references

Salila Kurra

1

1 reference

24 August 2017

Ethel Siris

series ordinal

2

1 reference

24 August 2017

publication date

1 July 2011

1 reference

Diabetes - Metabolism: Research and Reviews

24 August 2017

published in

1 reference

24 August 2017

volume

27

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

430-435

1 reference

An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

24 August 2017

cites work

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

21 January 2018

1 reference

Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis

21 January 2018

1 reference

Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden

21 January 2018

1 reference

Older women with diabetes have an increased risk of fracture: a prospective study

21 January 2018

1 reference

Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study

21 January 2018

1 reference

Diabetes and risk of fracture: The Blue Mountains Eye Study

21 January 2018

1 reference

Older women with diabetes have a higher risk of falls: a prospective study

21 January 2018

1 reference

Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats.

21 January 2018

1 reference

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

21 January 2018

1 reference

Regulation of osteoclast function and bone mass by RAGE.

21 January 2018

1 reference

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures

21 January 2018

1 reference

Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes

21 January 2018

1 reference

Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells

21 January 2018

1 reference

Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus

21 January 2018

1 reference

Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?

21 January 2018

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

Unraveling the mechanism of action of thiazolidinediones

21 January 2018

1 reference

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

21 January 2018

1 reference

Bone is a target for the antidiabetic compound rosiglitazone.

21 January 2018

1 reference

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

21 January 2018

1 reference

Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo

21 January 2018

1 reference

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

21 January 2018

1 reference

Thiazolidinedione use and bone loss in older diabetic adults

21 January 2018

1 reference

Thiazolidinediones and fractures: evidence from translating research into action for diabetes

21 January 2018

1 reference

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial

21 January 2018

1 reference

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women

21 January 2018

1 reference

7 January 2021

Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study

1 reference

7 January 2021

Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats

1 reference

7 January 2021

Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia

1 reference

7 January 2021

Vitamin D and calcium intake in relation to type 2 diabetes in women

1 reference

7 January 2021

Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men

1 reference

7 January 2021

Screening for osteoporosis in postmenopausal women: recommendations and rationale

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1197

1 reference

24 August 2017

1 reference